lunes, 4 de abril de 2016

Hemoglobinopathies Screening Guidance

Hemoglobinopathies Screening Guidance

Hemoglobinopathies Screening Guidance











CDC

CDC, in partnership with the Association of Public Health Laboratories,

has released new guidance for hemoglobinopathies screening:Hemoglobinopathies: Current Practices for Screening, Confirmation, and Follow-Up [PDF-3.6MB]. The hemoglobinopathies

are a group of inherited disorders (such as sickle cell disease and thalassemia)

in which hemoglobin—the protein in red blood cells that carries oxygen to the

tissues—is either abnormal or deficient. The guidance describes methods for 

hemoglobinopathy screening and diagnostic testing; discusses the methods' 

advantages and limitations; outlines important follow-up procedures for affected 

individuals; and more.

No hay comentarios:

Publicar un comentario